Navigation Links
Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf
Date:5/23/2013

;nnen, die jeweils unterschiedlichen Einstellungen zu der Erkrankung entsprechen.

Parameter Untergruppen[1] 1 2 3 4 Konform Überoptimistisch Bemüht Orientierungsbed. Probengröße 2264 1966 1633 2137 71 % 41 % 65 % weiblich 71 % weiblich weiblich weiblich Geschlecht 35 % männlich 29 % männlich 29 % männlich 59 % männlich 45 % unter 61 % unter 44 % unter oder oder oder 61 % unter gleich gleich gleich 35 oder gleich 35 35 35 Alter Jahre Jahre Jahre Jahre Sehr sicher bei eigenem Asthmamanagement 41 % 50 % 10 % 16 % Unkontrolliert gemäß GINA-Richtlinien 28 % 20 % 70 % 68 % Atemlosigkeit bei schnellem Gehen auf ebenem Boden oder Gehen auf einem kleinen Gefälle 28 % 33 % 47 % 41 % Wegen Asthma aufgewacht mehr oder gleich 1 Mal/Woche 41 % 32 % 70 % 78 % Möchten nicht als "krank" eingestuft werden 88 % 89 % 75 % 74 % Machen sich Sorgen wegen ihrem Asthma 11 % 4 % 61 % 32 % Halten ihr Asthma für ernst 18 % 9 % 58 % 35 % Glauben, dass Asthma sie vom vollen Leben abhält 12 % 11 % 59 % 54 % Sorgen sich um die Wirkung von Asthma für die Gesundheit in der Zukunft 41 % 25 % 83 % 64 % Besorgt darüber nicht zu wissen, wann nächster Asthmaanfall kommt 25 % 16 % 62 % 59 % Befolgen med. Anweisungen 91 % 74 % 83 % 55 % Benutzen den Inhalator zur Vorbeugung wie verschrieben 52 % 40 % 60 % 36 % Genieren sich, den Inhalator in Anwesenheit Anderer zu benutzen 15 % 29 % 48 % 57 % Sehen in der Teilnahme an einer Online-Gemeinschaft Vorteile für das eigene Management ihres Asthmas 24 % 19 % 44 % 59 % Suchen Informationen über Asthma öfter oder gleich 1 Mal/Woche 5 % 1 % 14 % 38 %

Mundipharma verpflichtet sich der Unterstützung von Forschungsbemühungen zur Entwicklung besserer Behandlungsstrategien für Asthma und damit Verringerung der individuellen und gesellschaftlichen Belastungen durch die Krankheit. Im Rahmen dieser Ve
'/>"/>

SOURCE Mundipharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Neue Studien beweisen die tödliche Verbindung zwischen Alkohol, Gewicht und Lebererkrankungen bei Frauen
2. Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain
3. Blutkrankheiten: Zehntausend europäische Hämatologen versammeln sich vom13.-16. Juni 2013 in Stockholm
4. Researchers untangle molecular pathology of giant axonal neuropathy
5. Blutkrankheiten: Europäische Hämatologen kommen vom 13. bis zum 16. Juni 2013 in Stockholm zusammen
6. Stemedica Issued U.S. Patent For Stem Cell Treatment of Diabetic Retinopathy and Diabetic Optic Neuropathy
7. Convergence Pharmaceuticals Announces Successful Completion of Phase I for CNV2197944 and Plans Phase II Studies in Neuropathic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... The empty capsules market is experiencing growth primarily ... innovations in the empty capsules market. The fast-growing ... of the empty capsules market. , Get Full ... Report , The report will enrich both established ... gauge the pulse of the market which in ...
(Date:12/19/2014)... NEW YORK , Dec. 18, 2014 ... novel therapies for the treatment of chronic pain, announced ... held today. "This was a transformational year ... a promising future for our company," said Sergio ... past year, we have executed on key financial, human ...
(Date:12/17/2014)... December 17, 2014 Ipsen Biopharmaceuticals, ... IPN; ADR: IPSEY), today announced that ... as Somatuline®) was approved by the U.S. Food ... gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients with ... metastatic disease to improve progression-free survival (PFS). , ...
(Date:12/17/2014)... Audacity, a leading California-based health and ... the Huntsworth Health Group, is proud to announce the ... her role, Gonzales will serve as Senior Vice President ... to welcome a talent of Jamie’s caliber to the ... “She is a proven healthcare innovation leader and brand ...
Breaking Biology Technology:Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
... 29 BioNeutral Group, Inc. ("BioNeutral") (OTC Bulletin Board: BONU), a chemical ... Scientist, Dr. Andrew Kielbania will appear on WVOX AM,s "In Focus" radio ... , The radio broadcast may be accessed via the Internet ... About Dr. Dan Miller , Dr. Miller is a retired ...
... England, July 29 In what will be the Stem ... seventh awareness rally, past patients, interested physicians, and prospective patients ... and discuss the various current treatments available throughout the world. ... is organizing the Manchester event. Mr. Clarke became involved in ...
... ... today that it is now offering its Linux and Open Source support services to ... support, the firm will be rapidly incorporating additional services over the next six months. ... Cambridge, MA ...
Cached Biology Technology:BioNeutral Group's CEO, Stephen Browand and Chief Scientist, Dr. Andrew Kielbania to Appear on WVOX 1460 AM 'In Focus' Radio Show Hosted by Dr. Dan Miller 2First U.K. Stem Cell Awareness Rally to Take Place in Manchester, England on August 9th, 2009 2First U.K. Stem Cell Awareness Rally to Take Place in Manchester, England on August 9th, 2009 3MUSA Technology Partners Introduces Linux/Open Source Service Desk 2MUSA Technology Partners Introduces Linux/Open Source Service Desk 3
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of the ... to their offering. One major ... of multimodal biometric systems. Multimodal biometric systems utilize ... verification and identification purposes. This helps to reduce ...
(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences ... monitoring, has released a new series of digital ... preclinical toxicology researchers. M series, part of the ... collect the best possible physiologic data when incorporating ... Adding functional endpoints to toxicology studies has evolved ...
(Date:12/10/2014)... 2014  Valencell, a leader in performance biometric data ... demand from its licensees for highly accurate, clinically validated ... solely coming from fitness and health sectors, but first ... wearable is only as useful as the biometric data ... driver in long-term mass consumer adoption of wearable products," ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... children and young adults for influenza is being seriously underestimated, ... historic vaccine programs have concentrated on the elderly and those ... computer modeling analysis was just published in the journal ... Health. The study suggests that children in school and young ...
... June 11, 2013 (BRONX, NY) Today, researchers ... Yeshiva University convened a one-day conference on Jewish genetics ... research. Such research could help scientists identify causes and ... common disorders afflicting the general population. The ...
... guarantee future support for international scientific collaborations funded by ... on a three year budgetary framework will extend the ... At an Intergovernmental Conference hosted by the European Commission ... governments that support the Human Frontier Science Program came ...
Cached Biology News:Flu vaccines aimed at younger populations could break annual transmission cycle 2Flu vaccines aimed at younger populations could break annual transmission cycle 3Albert Einstein College of Medicine hosts conference on Jewish genetic research 2
Mouse monoclonal [3F8 ] to smooth muscle Myosin heavy chain I ( Abpromise for all tested applications). entrezGeneID: 4629 SwissProtID: P35749...
Rabbit polyclonal to CAMK 1D beta ( Abpromise for all tested applications). entrezGeneID: 57118 SwissProtID: Q5SQQ7...
Request Info...
Goat polyclonal to HNF4 ( Abpromise for all tested applications). Antigen: Synthetic peptide: RLSKTLVDMDMADY (Human) N terminal. Entrez GeneID: 3172 Swiss Protein ID: P41235...
Biology Products: